Home
McCarthy Tétrault LLP
Fiona Legere
Fiona Legere
McCarthy Tétrault LLP
2020 Brings Growing Trend Of Patent Cases Decided By Way Of Summary Trial
06 Nov 2020 | Canada
First Trial Decision Under Canada's Amended Patented Medicines (Notice Of Compliance) Regulations Offers Guidance On Key Issues
05 May 2020 | Canada
PMPRB Draft Guidelines Published For Stakeholder Consultation
07 Jan 2020 | Canada
Federal Government Publishes Amendments Significantly Altering Canada's Patented Medicines Pricing Regime
23 Aug 2019 | Canada
Overhaul Of Canadian Pharmaceutical Pricing Regulations: Amendments To Be Published August 21, 2019
14 Aug 2019 | Canada
Federal Court Of Appeal Provides Important Guidance For Determining Jurisdiction Of The PMPRB
12 Jul 2019 | Canada
Canadian Patent Act Amendments Introduce File Wrapper Estoppel
21 Jan 2019 | Canada
Post-AstraZeneca: Has The Promise Doctrine Vanished From Patent Litigation? Likely, Yes
15 Oct 2018 | Canada
Federal Court Of Appeal Reaffirms: The Right Expert Is Critical
12 Oct 2018 | Canada
Ten Significant Changes To Canada's NOC Regulations
20 Jul 2017 | Canada
Federal Court Strikes Claim Where Allegations Of Patent Infringement Were Speculative
23 Jun 2017 | Canada
Fair, Reasonable And Non-Discriminatory: UK Patent Court Enjoins Huawei From Using Standard Essential Patents Owned By A Non-Practicing Entity
03 May 2017 | Canada
LOT Network
06 Apr 2017 | Canada
NPEs Beware: Contorted Construction Of A Patent Will Attract Elevated Costs
23 Jan 2017 | Canada
CETA Implementation In Canada: Bill C-30 Brings Significant Changes To The Canadian Patent System
16 Nov 2016 | Canada
New IP3 Patent Purchase Program Is Industry's Latest Attempt To Combat Trolls
27 Jul 2016 | Canada
Google's "FFF" Patent Plan: Find It, Fight It, And Get It For Free
10 Aug 2015 | Canada
Google's Patent Purchase Program: In The Public Interest Or A Monopoly On Patent Rights?
01 Jun 2015 | Canada
Beware Hubris – Janssen’s Infringement Of AbbVie’s Patent Gets Enjoined By The Federal Court
04 Aug 2014 | Canada
Recent Pair Of Rampiril Decisions Clarifies Limits On s. 8 Damages In Patent Law
25 Jul 2012 | Canada
< 1 2 >
20%
Very Popular: This author falls within the Top 20% for the below topics and industry categories
Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada for the topics, user groups and industry sectors listed below*:
Topics
  • Intellectual Property
  • Patent
Positions
  • CEO, Owner, Chairman, President, Mng Director
Industry
  • Pharmaceuticals & BioTech
  • Not For Profit
* Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.
Contact Details
Toronto
Email Website
66 Wellington Street West
Suite 5300, TD Bank Tower
Toronto
Canada
Telephone: 1-416-3621812

  © Mondaq® Ltd 1994 - 2021. All Rights Reserved.